Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | UGT2B7 | P16662 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2455708 | 0.89 | PPARD (0.44) | PPARDTSHRTP53TDP1AOX1 | |
| SCHEMBL11508933 | 0.79 | TSHR (0.46) | PPARDTSHRUGT2B7TP53TDP1 | |
| SCHEMBL10590815 | 0.79 | PPARD (0.54) | PPARDTSHRUGT2B7TP53TDP1 | |
| SCHEMBL16062694 | 0.79 | PPARD (0.54) | PPARDTSHRUGT2B7TP53TDP1 | |
| SCHEMBL16352174 | 0.73 | PPARD (0.48) | PPARDTSHRUGT2B7TP53TDP1 | |
| SCHEMBL28358625 | 0.73 | PPARD (0.44) | PPARDTSHRUGT2B7TP53TDP1 | |
| SCHEMBL3313657 | 0.72 | PPARD (0.70) | PPARDTSHRTP53TDP1 | |
| SCHEMBL5918893 | 0.71 | PPARD (0.50) | PPARDTSHRUGT2B7TP53TDP1 | |
| SCHEMBL5329595 | 0.71 | PPARD (0.50) | PPARDTSHRUGT2B7TP53TDP1 | |
| SCHEMBL10037944 | 0.71 | PPARD (0.50) | PPARDTSHRUGT2B7TP53TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9110069-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC (US) | 2015-08-18 | — | — | US | disclosed |
| US-20140086844-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC (US) | 2014-03-27 | — | — | US | disclosed |
| US-8552027-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC (US) | 2013-10-08 | — | — | US | disclosed |
| US-20120035346-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC | 2012-02-09 | — | — | US | disclosed |
| WO-2010083471-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC (US) | 2010-07-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140086844-A1 | LUMINESCENT COMPOUNDS | PHOSPHO1, PGLS, PFAS | PPARD 1479/4885TSHR 4592/4885UGT2B7 3144/4885 |
| US-20120035346-A1 | LUMINESCENT COMPOUNDS | PHOSPHO1, PGLS, PFAS | PPARD 1374/4885TSHR 4660/4885UGT2B7 3134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.